a
<We_can_help/>

What are you looking for?

>Rob de Jong
speaker_info

About The Speaker

Rob de Jong

Director, Antibody Research and Technology at Genmab

Rob de Jong

Dr. Rob N. de Jong has worked in different roles at the biotechnology company Genmab since 2007, related to molecular biology, CMC-supportive research, and protein engineering. Currently, Rob leads Genmab’s Antibody Format Development efforts, where his team marries rigorous science with playful protein engineering to address unsolved therapeutic challenges. His team applies biomolecular and structural insights to create novel therapeutic antibody platform technologies. Rob is an inventor of Genmab’s HexaBody® and HexElect® technologies, and after a workday of brewing ideas, he enjoys cooking Szechuanese dishes at home.

Single molecule studies and applications of antibodies engineered to induce cell surface-restricted hexamerization

Check back soon for abstract

The Antibody Series
Register now for free upcoming on-demand access to talks